SILENT-SEEDS
19.5.2022 11:37:07 CEST | Business Wire | Press release
Alexandre Lacarré, the co-founder of the Silent Seeds seed bank (formerly Dinafem) and the famous French rapper Booba, have announced a unique cooperation to create B-45, a seed specially designed for the artist. A first in Europe!
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220519005106/en/
With 20 years of experience and R&D, Silent Seeds was Booba's partner of choice for the creation and distribution of his own strain of cannabis, entirely tailor-made for an exceptional result.
Friday 20 May 2022 will mark the launch of B-45, an Indica-dominant hybrid resulting from crossing (Florida OG x Pre'98 Bubba Kush) x Orange Punch #66. This strain has a record THC content of more than 30%.
"If you want to visit Jamaica, you just have to taste my weed". - Booba
"From our first meeting, Booba knew exactly what he wanted. We soon came to the conclusion that the cannabis plant held no secrets for him. We would like to thank him and his whole team for their trust and the time they spent with us. This new strain is the result of months of testing and research. The B-45 will be presented at the various rounds of the Cannabis Cup 2023". - Alexandre Lacarré, Co-founder Silent Seeds
Silent Seeds mark the spectacular return of Dinafem, the company behind ground-breaking strains such as Moby Dick, Critical +2.0 and Original Amnesia. Thus, B-45 has benefited from the gene pool and the ancestral know-how now gathered at Silent Seeds. Its teams are recognized as some of the best geneticists worldwide in the cannabis sector.
The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220519005106/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 20266.8.2026 13:00:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026, and will participate in a fireside chat at 8:00am ET. Management will also participate in the Stifel Biotech Summit in Newport, Rhode Island, on August 10, 2026. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways We believe mental health patients deserve the possibility of a better future. Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under eva
Verdane Partners With Factbird to Accelerate Its Global Leadership Position in Manufacturing Intelligence6.8.2026 12:53:00 CEST | Press release
Verdane, the European specialist growth buyout investment firm, today announced a partnership and strategic majority investment in Factbird, a leading Danish IoT and recurring software company providing manufacturing intelligence solutions. The existing investors, Expedition Growth Capital and EIFO, are reinvesting significantly alongside Verdane. Factbird’s hardware-enabled software solutions help industrial businesses to improve productivity, reduce downtime and make more informed operational decisions that help manufacturers to gather, manage, analyse and act on production data to improve efficiency and reduce waste. Factbird’s customers experience increased production capacity and increased revenue leading to a very high return on investment that often lead to multi-million-dollar improvements. The company serves more than 300 customers including many global blue-chip customers and has established a global leadership position within digital manufacturing and industrial software int
Purina Named as First Publicly Announced NIQ ConnectAI Charter Client6.8.2026 12:45:00 CEST | Press release
Purina is among the first companies working with NIQ forward-deployed engineers to bring consumer intelligence into enterprise AI workflowsFive global companies have joined the ConnectAI Charter Program, with individual client announcements and case studies to follow across personal care, pet care, beauty and beverages NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today named Purina as the first publicly announced client in its ConnectAI Charter Program. The announcement follows NIQ’s launch of the program with five global organizations across personal care, pet care, beauty and beverages, with additional client announcements and case studies expected as engagements advance. Through ConnectAI, NIQ forward-deployed engineers and data scientists are working within Purina’s technology environment to explore how NIQ consumer and market intelligence can support everyday AI-enabled workstreams and help teams access relevant insights more efficiently. "Understanding the nee
Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin6.8.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today it is working with the U.S. Department of Verterans Affairs (VA) on a multi-site randomized controlled clinical trial. The study will evaluate the safety and efficacy of COMP360 psilocybin in the treatment of treatment-resistant depression (TRD) in veterans, including those with concurrent post-traumatic stress disorder (PTSD). The trial, titled "Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression," or PIVOT, reflects VA’s commitment to pursuing innovative solutions for veterans who have not responded to existing treatments. Compass will donate the study drug - COMP360, a synthetic, proprietary pharmaceutical-grade formulation of psilocybin optimized for stability and purity. Compass will support the education and training of the investigators and their training team through the provision of training
Great Britain Leads Europe’s FMCG Inflation as NIQ Launches New Inflation Barometer6.8.2026 09:00:00 CEST | Press release
NIQ (NYSE: NIQ) today launches its new EU5 FMCG Inflation Barometer - a monthly tracker across five Western Europe markets – France, Great Britain, Germany, Italy and Spain – designed to help retailers, manufacturers and the media understand how inflation is evolving across Europe’s largest grocery markets and how shoppers are responding. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806579111/en/ EU5 CPG Inflation slows to +1.1% The first edition of the Barometer reveals that while inflation across Europe’s FMCG sector remains relatively contained overall, significant differences persist between countries. Key findings include: Great Britain recorded the highest FMCG inflation across the EU5 at +2.3%1, above the European average of +1.1%. France and Italy reported the lowest inflation at -0.4% and +0.6% retrospectively, highlighting the uneven inflationary landscape across Europe's major economies. The monthly Barometer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom